ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TESB Tessenderlo Group

24.40
0.10 (0.41%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Tessenderlo Group EU:TESB Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 0.41% 24.40 24.15 24.90 24.40 24.20 24.30 13,030 16:40:00

Tessenderlo Group completes sale of pharmaceutical ingredients activities

12/12/2012 6:01am

GlobeNewswire


Tessenderlo Group (NYSE Euronext: TESB) announced today that it has completed the sale of its pharmaceutical ingredients activities in Calaire (France) and Farchemia (Italy) to International Chemical Investors Group (ICIG), a private industrial holding company.

On October 9 2012, the group announced its intention to divest the pharmaceutical ingredients activities Calaire and Farchemia. Information and consultation procedures were completed early November.  After clearance by the merger control authorities , the sale was completed on  December 5  2012.

This divestment is in line with Tessenderlo Group's strengthened focus on specialty products and services in the areas of food, agriculture, water management and valorizing bio-residuals.

Calaire and Farchemia employ some 360 employees.

Tessenderlo Group is a worldwide specialty company, focused on food, agriculture, water management and on valorizing bio-residuals. The group employs about 7,500 people and is a leader in most of its markets, with a consolidated revenue of 2.1 billion EUR in 2011.  Tessenderlo Chemie NV is listed on NYSE Eurolist by Euronext Brussels and is part of Next 150 and BEL Mid indices. Financial News wires: Bloomberg: TESB BB - Reuters: TesBt.BR - Datastream: B:Tes

International Chemical Investors Group (ICIG) is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses. Since inception in 2004, ICIG has acquired 17 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. ICIG companies currently employ more than 3,300 people and operate 17 manufacturing facilities in Europe and the United States with total sales of approximately €700 million. For more info about International Chemical Investors Group:  http://www.ic-investors.com

Media Relations      Investor Relations
Kathleen IWENS      Philip LUDWIG
Tel: +32 (0) 478 664 555      Tel: +32 2 639 16 58

 

This press release is available in Dutch, French and English on the corporate website www.tessenderlogroup.com  - under 'News & Media'  

Pour lire le communiqué de presse complet en Français, cliquez ici
To read the full press release in English, click here
Hier kan je het volledige bericht in het Nederlands lezen



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Tessenderlo Group via Thomson Reuters ONE

HUG#1664104

1 Year Tessenderlo Chart

1 Year Tessenderlo Chart

1 Month Tessenderlo Chart

1 Month Tessenderlo Chart

Your Recent History

Delayed Upgrade Clock